Studies have confirmed that the PD-1/PD-L1 signaling pathway is connected with many diseases closely, such as cancer, particularly non-small-cell lung cancer [16], and autoimmune diseases, SLE (systemic lupus erythematosus) [17], T1D [18], and rheumatoid arthritis [19]. Here, CD274 is linked to cancer.